-
201
Therapeutic Approaches for Peripheral and Central Neuropathic Pain
Published 2019-01-01“…As first-line pharmacological treatment options, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and gabapentinoids are recommended. …”
Get full text
Article -
202
Selective activation of SIGMAR1 in anterior cingulate cortex glutamatergic neurons facilitates comorbid pain in depression in male mice
Published 2025-01-01“…These results revealed a previously unknown neural mechanism for depression and pain comorbidity and provided new mechanistic insights into the antidepressive and analgesic effects of the disease.…”
Get full text
Article -
203
Putative Mechanism of Action of Trazodone-Related Oromandibular Dyskinesia
Published 2024-01-01“…As opposed to other antidepressants, trazodone has a mechanism of action which can account for both the development and treatment of dyskinetic movements. …”
Get full text
Article -
204
A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain
Published 2022-05-01“…Pain medications have been the mainstay of treatment for chronic pain conditions with an increasing use of membrane stabilizers and antidepressants to treat neuropathic pain conditions. …”
Get full text
Article -
205
Eagle Syndrome: Pathophysiology, Differential Diagnosis and Treatment Options
Published 2023-02-01“…Medical treatment options include steroids, antidepressants, and anticonvulsants however not all cases of Eagle Syndrome can be managed medically. …”
Get full text
Article -
206
Koro Syndrome: Epidemiology, Psychiatric and Physical Risk Factors, Clinical Presentation, Diagnosis, and Treatment Options
Published 2023-02-01“…In sporadic Koro, it is believed that if the primary psychiatric disorder is treated with anxiolytics, antidepressants, sedatives, or psychotics, the secondary Koro-like symptoms will also fade. …”
Get full text
Article -
207
Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
Published 2012-01-01“…Central neuropathic pain in patients with multiple sclerosis (MS) is a common debilitating symptom, which is mostly treated with tricyclic antidepressants or antiepileptics. Unfortunately, the use of these drugs is often limited due to adverse events. …”
Get full text
Article -
208
Fibromyalgia: Presentation and Management with a Focus on Pharmacological Treatment
Published 2008-01-01“…Controlled trials of antidepressants, gabapentinoids, tramadol, zopiclone and sodium oxybate have shown effectiveness in fibromyalgia patients. …”
Get full text
Article -
209
A Comprehensive Review of Celecoxib Oral Solution for the Acute Treatment of Migraine
Published 2022-04-01“…Preventative therapies include tricyclic antidepressants, calcium channel blockers, beta-blockers, and anticonvulsants. …”
Get full text
Article -
210
Pain at chronic pancreatitis: origin and treatment options
Published 2015-07-01“…Efficacy of analgetics can be increased by coadministration of psychotropic agents, most often — tricyclic antidepressants. In severe cases intractable pain at a chronic pancreatitis itself can become indication to surgical intervention.Conclusion. …”
Get full text
Article -
211
Pharmacotherapeutic Options for Managing Neuropathic Pain: A Systematic Review and Meta-Analysis
Published 2021-01-01“…Trial outcomes were generally modest even for first-line drugs such as tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, and gabapentinoids. …”
Get full text
Article -
212
Current Evidence on Atypical Odontalgia: Diagnosis and Clinical Management
Published 2012-01-01“…(v) Are there any characteristic symptoms of AO other than spontaneous pain? (vi) Are antidepressants effective for treatment of AO? (vii) Are anticonvulsants effective for treatment of AO? …”
Get full text
Article -
213
Synaptic plasticity in fronto-insular circuits underlying stress susceptibility and resilience
Published 2025-02-01“…In this review, we examine how chronic stress and antidepressants modulate synaptic connectivity in stress-sensitive brain circuits. …”
Get full text
Article -
214
Recurrent Catatonia due to Episodic Obsessive-Compulsive Disorder
Published 2022-01-01“…A combination of ECT and antidepressants with ERP therapy for recurrent catatonia with OCD could be effective as a therapeutic modality.…”
Get full text
Article -
215
Ketamine for the Treatment of Chronic Pain: A Comprehensive Review
Published 2021-07-01“… # Conclusion First-line treatment for many chronic pain conditions includes NSAIDs, antidepressants, anticonvulsants, and opioids. However, these treatment methods are unsuccessful in a subset of patients. …”
Get full text
Article -
216
Effect of Intranasal Calcitonin in a Patient with McCune-Albright Syndrome, Fibrous Dysplasia, and Refractory Bone Pain
Published 2017-01-01“…She was diagnosed with MAS at 4 years of age and, during follow-up, she had multiple pathological fractures and bone pain refractory to treatment with bisphosphonates, tricyclic antidepressants, and opioids. The pain was incapacitating and the patient required a wheelchair. …”
Get full text
Article -
217
Recent advances in understanding and managing body dysmorphic disorder
Published 2017-08-01“…The recommended treatments for BDD are outlined, namely cognitive behavioural therapy (CBT) and antidepressants, such as selective serotonin reuptake inhibitors. …”
Get full text
Article -
218
Zuranolone for postpartum depression: a systematic review and meta-analysis of two randomized studies
Published 2025-01-01“…Zuranolone was significantly associated to an improvement of Clinical Global Impression response rate; Hamilton Depression Rating Scale 15 days and 45-day remission, 3-day, 15-day, and 45-day symptom remission, and reduction in the dose of antidepressants. As for safety outcomes, it was noticed that zuranolone increases sedation risk, which can be dose related. …”
Get full text
Article -
219
S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study
Published 2013-01-01“…Thirty-three outpatients with major depressive episode who failed to respond to at least 8 weeks of treatment with two adequate and stable doses of antidepressants were treated openly with fixed dose of SAMe (800 mg) for 8 weeks, added to existing medication. …”
Get full text
Article -
220
Narcolepsy treatment: from exorcism and bloodletting to modern therapy with histamine receptor inverse agonists
Published 2020-09-01“…Serotonin and noradrenaline reuptake inhibitors were also often prescribed to manage cataplexy, while low doses of tricyclic antidepressants were used as third-line treatment. In this paper, we also present new European management guidelines for narcolepsy presented in 17th European Narcolepsy Masterclass in Berlin in September 5, 2020. …”
Get full text
Article